Physician profile
Christopher D Leville
NPI 1699776310
$30,295.29
in general payments reported to CMS, 2019-2025
15 companies · $14K in 2025
The $14K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,274 · 2020: $144 · 2021: $455 · 2022: $468 · 2023: $3,571 · 2024: $7,064 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $3,323 · Food and Beverage: $3,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,550.00 |
| Travel and Lodging | $3,322.86 |
| Food and Beverage | $3,081.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $9,222.78 | 2024-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Surmodics, INC. | $8,409.61 | 2023-2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Boston Scientific Corporation | $2,540.37 | 2023-2025 | Sterling, Ranger, Eluvia |
| Penumbra, INC. | $2,482.55 | 2020-2025 | Indigo System |
| Abbott Laboratories | $2,035.42 | 2019 | |
| Medtronic Vascular, INC. | $1,952.27 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,531.31 | 2019-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $805.08 | 2021-2024 | Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $468.67 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $210.24 | 2024 | Cook, Zenith |
| Shockwave Medical, INC | $176.77 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $150.71 | 2022-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $131.80 | 2019 | |
| Philips North America LLC | $96.30 | 2025 | Peripheral Vascular Undivided |
| Reflow Medical INC | $81.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Leville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.